Studies in patients with type 2 diabetes and obesity have demonstrated that the use of SGLT2 inhibitors, particularly empagliflozin, not only increases overall cancer risk but also significantly elevates the risk of bladder cancer [10, 108]
Compounded medications from licensed 503A pharmacies follow pharmaceutical-grade standards and must meet United States Pharmacopeia criteria
The breadth of these trials suggests Lilly sees retatrutide as a cornerstone product with applications far beyond weight loss
Work with your doctor by ensuring they have all relevant medical records, asking them to include detailed clinical notes in the prior authorization, requesting they document previous medication failures thoroughly, and asking for a specialist referral (endocrinologist) if that improves coverage chances with your plan
You are still on the starting dose The 2mg starting dose produces minimal appetite effects for most people
Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
